medication Botulinum A injection.

PreclinicalSmall molecule

medication Botulinum A injection. is one of 6 small molecule programs targeting Spastic Cerebral Palsy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Spastic Cerebral PalsyActive, not recruiting

Spastic Cerebral PalsyPreclinical

Active, not recruiting

Competition

Competitive Landscape

5 competitors in Spastic Cerebral Palsy

#DrugCompanyPhaseTrials

XEOMIN

MMerz Pharmaceuticals GmbH

Dysport

1 3

Botox

RRevance Therapeutics, Inc.

Preclinical

2 4

Botulinum Toxin

MMeshalkin Research Institute of Pathology of Circulation

Preclinical

1 5

Human Amniotic Epithelial Cells

SShanghai East Hospital

Phase 1

1 6

medication Botulinum A injection.

JJu Seok Ryu

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Spastic Cerebral Palsy1 trial

The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study

Completed·JJu Seok Ryu·N/A·NCT03680196·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for medication Botulinum A injection.. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — medication Botulinum A injection. compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for medication Botulinum A injection.. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ju Seok Ryu company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: JJu Seok Ryu

medication Botulinum A injection.

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Spastic Cerebral Palsy1 trial

References

Drug Info

Quick Facts

Related News